PANORA ROBERT A 4/A

4/A · TECOGEN INC. · Filed Jul 14, 2025

Form 4/AAmended

Period: 2025-06-03

COO and President

Transactions

Sale
Common Stock
2025-06-04$5.00/sh−31,000$155,000→ 13,000 total
Sale
Common Stock
2025-06-03$4.69/sh−26,000$121,940→ 44,000 total
Exercise/Conversion
Common Stock
2025-06-16$0.79/sh+12,723$10,000→ 25,723 total
Exercise/Conversion
Common Stock
2025-06-16$1.10/sh+52,500$57,750→ 108,223 total
Sale
Common Stock
2025-06-18$5.03/sh−13,000$65,390→ 95,223 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-16$0.79/sh−12,723$10,000→ 0 total
Exercise: $0.79From: 2016-05-12Exp: 2026-05-12→ Common Stock (12,723 underlying)
Exercise/Conversion
Common Stock
2025-06-16$0.71/sh+30,000$21,300→ 55,723 total
Sale
Common Stock
2025-06-23$6.36/sh−31,800$202,248→ 63,423 total
Sale
Common Stock
2025-06-24$6.86/sh−900$6,174→ 62,523 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-16$0.71/sh−30,000$21,300→ 100,000 total
Exercise: $0.71Exp: 2030-07-09→ Common Stock (30,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-16$1.10/sh−52,500$57,750→ 0 total
Exercise: $1.10From: 2023-01-21Exp: 2032-01-21→ Common Stock (52,500 underlying)

Footnotes (3)

[F1]Share sales effected to cover tax liabilities and other obligations. The June 2025 share sales were reported to the company on July 11, 2025.
[F2]Transaction code corrected
[F3]100,000 shares of the 200,000 option shares granted pursuant to Stock Option Agreement dated 7/9/2020 vested on 6/30/2022 upon achievement of Adjusted EBITDA performance milestone.

Documents

1 file